License. Agent is hereby granted an irrevocable, non-exclusive license or other right to use, license or sub-license (without payment of royalty or other compensation to any Person) any or all Intellectual Property of Borrowers, computer hardware and software, trade secrets, brochures, customer lists, promotional and advertising materials, labels, packaging materials and other Property, in advertising for sale, marketing, selling, collecting, completing manufacture of, or otherwise exercising any rights or remedies with respect to, any Collateral. Each Borrowers rights and interests under Intellectual Property shall inure to Agents benefit.
License. The Agent is hereby granted a license or other right to use, following the occurrence and during the continuance of a Default, without charge, the Debtor's labels, patents, copyrights, rights of use of any name, trade secrets, trade names, trademarks, service marks, customer lists and advertising matter, or any property of a similar nature, as it pertains to the Collateral, in completing production of, advertising for sale, and selling any Collateral, and, following the occurrence and during the continuance of a Default, the Debtor's rights under all licenses and all franchise agreements shall inure to the Agent's benefit. In addition, the Debtor hereby irrevocably agrees that the Agent may, following the occurrence and during the continuance of a Default, sell any of the Debtor's Inventory directly to any person, including without limitation persons who have previously purchased the Debtor's Inventory from the Debtor and in connection with any such sale or other enforcement of the Agent's rights under this Agreement, may sell Inventory which bears any trademark owned by or licensed to the Debtor and any Inventory that is covered by any copyright owned by or licensed to the Debtor and the Agent may finish any work in process and affix any trademark owned by or licensed to the Debtor and sell such Inventory as provided herein.
License. Without limiting the generality of any other Security Document, the Borrower hereby grants to the Lender a non-exclusive, worldwide and royalty-free license to use or otherwise exploit all Intellectual Property Rights of the Borrower for the purpose of: (a) completing the manufacture of any in-process materials during any Default Period so that such materials become saleable Inventory, all in accordance with the same quality standards previously adopted by the Borrower for its own manufacturing and subject to the Borrowers reasonable exercise of quality control; and (b) selling, leasing or otherwise disposing of any or all Collateral during any Default Period.
License. RDSI is granted the nonexclusive, worldwide, noncancellable license to use, copy, prepare derivative works of, distribute, and perform or display publicly, modify and have modified the Software and to distribute derivative works of same solely to provide support and maintenance of the Software (including but not limited to maintaining regulatory compliance) and fulfilling RDSI's other obligations under existing Customer Agreements (including financial institutions which have signed a Customer Agreement but have not yet started using the Software). For the avoidance of doubt, this license grant shall not include the present right to possess the source code version of the Software, which shall occur only as a result of Section 13.2 or under the terms of the Escrow Agreement described in Section 13.1. This license includes the right retain third parties to assist RDSI in the exercise of the rights in the Software and derivative works granted to RDSI in this Section 13.3. The licenses granted in this Section 13.3 shall be deemed to be, for purposes of Section 365(n) of the U.S. Bankruptcy Code as licenses to rights in "intellectual property" as defined in Section 101 of the U.S. Bankruptcy Code.
License. During Executive's employment and after Executive's employment with the Company terminates, Executive grants to the Company an irrevocable, nonexclusive, worldwide, royalty-free license to (a) make, use, sell, copy, perform, display, distribute or otherwise utilize copies of the Licensed Materials; (b) prepare, use and distribute derivative works based upon the Licensed Materials; and (c) authorize others to do the same. Executive shall notify the Company in writing of any Licensed Materials Executive delivers to the Company.
License. To the extent that any pre-existing materials are contained in the materials Executive delivers to the Company or the Companys customers, and such preexisting materials are not Work Product, Executive grants to the Company an irrevocable, nonexclusive, worldwide, royalty-free license to: (a) use and distribute (internally or externally) copies of, and prepare derivative works based upon, such pre-existing materials and derivative works thereof, and (b) authorize others to do any of the foregoing. Executive shall notify Company in writing of any and all pre-existing materials delivered to the Company by Executive.
License. Subject to the terms of this Agreement, Kamada hereby grants to Baxter and its Affiliates an exclusive, royalty-free right and license, with the right to grant sublicenses, in the Field in the Baxter Territory under the Kamada Intellectual Property, that is necessary or useful to enable Baxter to promote, import, export, use (in a manner consistent with the activities contemplated by this Agreement or any Related Agreement), offer to sell, sell, have sold and distribute the Product in the Field in the Baxter Territory under and in accordance with this Agreement. Kamada shall not grant any licenses under the Kamada Intellectual Property to any Third Party to promote, import, export, use, offer to sell, sell, have sold or distribute any Competing Product in the Field in the Baxter Territory.
License. Subject to the terms and conditions of this Agreement, SVI hereby grants to CPI an exclusive, sublicensable, worldwide license under the Surgi-Vision IP, including but not limited to the Billabong Patents (the License), to make, have made, use, promote, market, import, distribute, lease, sell, offer for sale and commercialize the Licensed Products in the Implantable Cardiac Field for the term of this Agreement. SVI further grants CPI the right to adapt the Surgi-Vision IP to a commercial form suitable for incorporation into CPIs and its Affiliates product(s) in the Implantable Cardiac Field. For the avoidance of doubt, the sole and exclusive nature of the License herein granted being acknowledged, SVI, including any transferee, assignee or successor thereof or its Third Party Licensors, shall have no right to deal in any way with (or exercise any right herein granted to CPI with respect to) the Surgi-Vision IP or any Licensed Product (including to manufacture, promote, market, distribute, sell, offer for sale and/or commercialize Licensed Products) within the Implantable Cardiac Field, and any such purported right shall be null and void; provided, however, that the foregoing shall not apply with respect to: (a) any lien or security interest in the Surgi-Vision IP; (b) any rights retained by JHU under the JHU Agreements; (c) to the extent a Patent was supported by federal funding obtained by JHU, any rights, conditions and limitations imposed by U.S. law (including any royalty-free non-exclusive license granted to the U.S. government pursuant to U.S. law and any requirement that products used or sold in the U.S. be manufactured substantially in the U.S.); and (d) any right to author, to publish and to retain or transfer copyright to scientific reports retained by SVI or SVIs collaborators or granted by SVI to Third Parties. The Parties hereby further agree and confirm that the terms and conditions of the License granted herein, including the aforesaid exclusivity, shall survive any Change in Control of SVI or the assignment, transfer or sale of all or substantially all of its assets, by operation of law or otherwise.
License. Legacy hereby grants Primary and its Affiliates an exclusive license, with rights of sublicense as further described below, in the Primary Field under the Legacy Patents and Legacy Know-How to make, have made, use, sell, or import CDCs, any Derivatives thereof, and Viamet Collaboration Derived Products in the Territory. Legacy hereby further grants Primary and its Affiliates an exclusive license, with rights of sublicense as further described below, in the Primary Field under Legacy Know-How to make, have made, use, sell, or import VDCs, any Derivatives thereof, and any products incorporating any of the foregoing in the Territory. Except as described in Section 7.2(c), 7.2(d), or 12.5(b), the licenses granted in this Section 4.3(a) shall be perpetual.
License. Subject to the terms and conditions of this Agreement, Sonics hereby grants to Licensee a nonexclusive, nontransferable and worldwide license under Sonics Intellectual Property Rights, to: (a) internally use the Deliverables for the design and development of Devices and for the Term indicated in the Technology Schedule; (b) manufacture, have manufactured, sell, import, and otherwise distribute and dispose of (subject to the payment of royalties under Section 5.2 below) the Devices developed under the license granted in Sections 2.1(a) and 2.8; and (c) subject to the provisions of Section 2.10, sublicense to Sublicensees (i) the rights and licenses in the same scope as granted in Sections 2.1 (a) and 2.8 and (ii) the rights to manufacture, and have manufactured Devices and (iii) the rights to sell, import, and otherwise distribute the Devices developed and manufactured under the licenses granted in Section 2.1(c)(i) and (ii), and further subject to the payment of license fees and royalties under Section 5 below and under Section 7 of the Technology Schedule. In addition, notwithstanding any provision to the contrary elsewhere in this Agreement, Licensee shall have the right to sublicense to Subsidiaries the rights and licenses in the same scope as granted to Licensee under this Agreement; provided however, that such Subsidiaries shall agree to be bound by substantially the same terms as are applicable to Licensee in this Agreement.